Raymond James Financial
GLSI icon

Raymond James Financial’s Greenwich LifeSciences GLSI Stock Holding History

Raymond James Financial’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$236K Buy
+9,837
New +$257K ﹤0.01% 4799
2025
Q3 		– Sell
-718
Closed -$6.51K – 5667
2025
Q2 		$6.51K Buy
+718
New +$6.83K ﹤0.01% 6081

Other funds holding GLSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Raymond James Financial's GLSI Position: Q1 2026 in Review

Raymond James Financial opened a new position in Greenwich LifeSciences (GLSI) in Q1 2026: 9,837 shares worth $236K. The stake represents ﹤0.01% of the portfolio and ranks #4799 among its holdings. This is a return to the name: Raymond James Financial previously reported a position in GLSI as recently as Q2 2025.

Raymond James Financial first reported a position in GLSI in Q2 2025 and has held it in 2 quarters since. 64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.

  • Raymond James Financial held 9,837 shares of Greenwich LifeSciences worth $236K as of Q1 2026.
  • Greenwich LifeSciences was a new Raymond James Financial position in Q1 2026.
  • Greenwich LifeSciences made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #4799 holding.
  • Raymond James Financial first reported a position in Greenwich LifeSciences in Q2 2025 and has held it in 2 quarters since.
  • 64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.